THSD7B and cancer: Further analysis using the TCGA database’s pan-cancer dataset revealed a broadly positive correlation between THSD7B and various immune cells across different cancer types, which suggested THSD7B can be a positive factor for immune microenvironment and immunotherapy (Figure 5C).